Abrdn Life Sciences Investors HQL
Set alert
17.98 USD -0.46 -2.49%
At close · Nov 2
17.97 -0.01 -0.05%
After hours · Nov 2, 4:01 PM ET
17.89 Day range 19.00
15.66 52-week range 22.67
- YTD
- +7.15%
- 1 year
- +1.30%
- Open
- 18.42
- Prev close
- 18.44
- Mkt cap
- 546.74M
- Vol
- 79.33K
- Avg vol
- 133.35K
- EPS
- 6.64
- P/E
- 2.71
- Div yield
- 14.12%
More statistics
- Low
- 17.89
- High
- 19.00
- Forward P/E
- 0.00
- Beta
- 0.70
- Short ratio
- 0.41
- Inst. own
- 35.35%
- Dividend
- 2.00
- Ex-div date
- Nov 20, 2024
- 50-d avg
- 14.47
- 200-d avg
- 14.34
- 1y target
- 0.00
5Y chart
Events in this range
- Nov 23, 2021Dividend: 0.42
- Feb 24, 2022Dividend: 0.39
- May 26, 2022Dividend: 0.35
- Aug 25, 2022Dividend: 0.31
- Nov 23, 2022Dividend: 0.31
- Dec 30, 2022Dividend: 0.31
- Feb 24, 2023Dividend: 0.33
- May 24, 2023Dividend: 0.32
- Aug 24, 2023Dividend: 0.32
- Nov 21, 2023Dividend: 0.3
- Feb 21, 2024Dividend: 0.39
- May 22, 2024Dividend: 0.48
- Aug 23, 2024Dividend: 0.49
- Nov 21, 2024Dividend: 0.5
- Feb 21, 2025Dividend: 0.47
- May 22, 2025Dividend: 0.43
- Aug 22, 2025Dividend: 0.42
- Nov 21, 2025Dividend: 0.5
- Feb 20, 2026Dividend: 0.56
- May 21, 2026Dividend: 0.56
- Aug 24, 2026Dividend: 0.62
Signals (90)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 14, 2026 | 1 month ago |
| SMA: Bearish | Sep 7, 2026 | 1 month ago |
| RSI: Overbought | Aug 17, 2026 | 2 months ago |
| MACD: Buy Signal | Jun 22, 2026 | 4 months ago |
| SMA: Bullish | Jun 15, 2026 | 4 months ago |
| SMA: Bullish | Jun 15, 2026 | 4 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| MACD: Sell Signal | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | May 25, 2026 | 5 months ago |
| SMA: Bearish | May 18, 2026 | 5 months ago |
| MACD: Buy Signal | Apr 27, 2026 | 6 months ago |
| SMA: Bullish | Mar 30, 2026 | 7 months ago |
| SMA: Bullish | Mar 30, 2026 | 7 months ago |
| SMA: Bearish | Mar 16, 2026 | 7 months ago |
| SMA: Bullish | Mar 9, 2026 | 7 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| SMA: Bearish | Feb 16, 2026 | 8 months ago |
| SMA: Bullish | Feb 9, 2026 | 8 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
| SMA: Bullish | Jan 19, 2026 | 9 months ago |
| SMA: Bearish | Dec 29, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 29, 2025 | 10 months ago |
| SMA: Bullish | Dec 22, 2025 | 10 months ago |
| SMA: Bearish | Dec 15, 2025 | 10 months ago |
| RSI: Overbought | Sep 29, 2025 | 1 year ago |
| SMA: Bullish | Jun 30, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 2, 2025 | 1 year ago |
| SMA: Bullish | May 19, 2025 | 1 year ago |
| SMA: Bearish | May 5, 2025 | 1 year ago |
| SMA: Bullish | Apr 28, 2025 | 1 year ago |
| RSI: Oversold | Mar 31, 2025 | 1 year ago |
| SMA: Bearish | Feb 24, 2025 | 1 year ago |
| SMA: Bullish | Jan 20, 2025 | 1 year ago |
| SMA: Bearish | Nov 11, 2024 | 1 year ago |
| SMA: Bearish | Nov 11, 2024 | 1 year ago |
| SMA: Bullish | Nov 4, 2024 | 1 year ago |
| SMA: Bearish | Oct 21, 2024 | 2 years ago |
| SMA: Bullish | Oct 14, 2024 | 2 years ago |
| SMA: Bearish | Sep 23, 2024 | 2 years ago |
| MACD: Sell Signal | Sep 23, 2024 | 2 years ago |
| SMA: Bullish | Sep 9, 2024 | 2 years ago |
| SMA: Bearish | Sep 2, 2024 | 2 years ago |
| RSI: Overbought | Jul 22, 2024 | 2 years ago |
| MACD: Buy Signal | Jun 10, 2024 | 2 years ago |
| SMA: Bullish | Jun 3, 2024 | 2 years ago |
| SMA: Bullish | Jun 3, 2024 | 2 years ago |
| SMA: Bearish | May 27, 2024 | 2 years ago |
| SMA: Bearish | May 27, 2024 | 2 years ago |
| MACD: Sell Signal | May 27, 2024 | 2 years ago |
| MACD: Buy Signal | May 13, 2024 | 2 years ago |
| SMA: Bullish | Apr 29, 2024 | 2 years ago |
| SMA: Bullish | Apr 29, 2024 | 2 years ago |
| SMA: Bearish | Apr 8, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 1, 2024 | 2 years ago |
| SMA: Bearish | Mar 4, 2024 | 2 years ago |
| SMA: Bullish | Dec 11, 2023 | 2 years ago |
| MACD: Buy Signal | Dec 4, 2023 | 2 years ago |
| RSI: Oversold | Oct 16, 2023 | 3 years ago |
| MACD: Sell Signal | Aug 21, 2023 | 3 years ago |
| SMA: Bullish | Jul 17, 2023 | 3 years ago |
| MACD: Buy Signal | Jul 17, 2023 | 3 years ago |
| MACD: Sell Signal | Jul 3, 2023 | 3 years ago |
| SMA: Bearish | Jun 26, 2023 | 3 years ago |
| SMA: Bullish | Jun 19, 2023 | 3 years ago |
| MACD: Buy Signal | Jun 12, 2023 | 3 years ago |
| MACD: Sell Signal | May 22, 2023 | 3 years ago |
| MACD: Buy Signal | Apr 17, 2023 | 3 years ago |
| SMA: Bullish | Apr 10, 2023 | 3 years ago |
| MACD: Sell Signal | Feb 27, 2023 | 3 years ago |
| SMA: Bearish | Feb 6, 2023 | 3 years ago |
| SMA: Bearish | Feb 6, 2023 | 3 years ago |
| SMA: Bullish | Jan 23, 2023 | 3 years ago |
| SMA: Bullish | Jan 23, 2023 | 3 years ago |
| SMA: Bearish | Jan 16, 2023 | 3 years ago |
| SMA: Bearish | Jan 16, 2023 | 3 years ago |
| SMA: Bullish | Jan 9, 2023 | 3 years ago |
| SMA: Bullish | Jan 2, 2023 | 3 years ago |
| SMA: Bearish | Dec 12, 2022 | 3 years ago |
| SMA: Bullish | Nov 7, 2022 | 3 years ago |
| SMA: Bullish | Oct 24, 2022 | 4 years ago |
| MACD: Buy Signal | Oct 17, 2022 | 4 years ago |
| MACD: Sell Signal | Oct 10, 2022 | 4 years ago |
| SMA: Bearish | Aug 22, 2022 | 4 years ago |
| SMA: Bearish | Aug 15, 2022 | 4 years ago |
| SMA: Bullish | Aug 8, 2022 | 4 years ago |
| SMA: Bullish | Jun 27, 2022 | 4 years ago |
| RSI: Oversold | Apr 25, 2022 | 4 years ago |
| SMA: Bullish | Mar 28, 2022 | 4 years ago |
Key statistics
- Market cap
- 377.99M
- Enterprise value
- 0
- Trailing P/E
- 4.43
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 107.60
- Price / book
- 0.84
- EPS (TTM)
- 3.04
- Beta
- 0.70
- Dividend yield
- 14.12%
- Payout ratio
- 54.61%
- Profit margin
- 156.45%
- Revenue (TTM)
- 3.51M
- Revenue growth
- 7.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 1.28%
- Shares outstanding
- 28.06M
- Short % of float
- 0.00%
- 50-day average
- 14.47
- 200-day average
- 14.34
Analyst view
Consensus: none
Price target (mean) 0.00
Next earnings
Consensus EPS estimate 0.00.
About Abrdn Life Sciences Investors
Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.
- Sector
- Financial Services
- Industry
- Asset Management
- Country
- United States
News
- Analysis Of Abrdn Healthcare Investors (HQL): The Fund Is Currently Overvalued
- 10 Best CEFs This Month: Average Yield Of 10% (September 2026)
- HQL: The Rally That Makes Growth Harder (Rating Downgrade)
- 10 Best CEFs This Month: Average Yield Of Near 10% (August 2026)
- 10 Best CEFs This Month: Average Yield Of Near 10% (July 2026)
- HQL: Attractive Outlook With Growth Of GLP-1 Market
- Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts
- How To Invest $100,000 Today: 5 Strategies For Success
- Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details
- 10 Best CEFs This Month: Average Yield Of 10% (March 2026)
Your note
Sign in to keep a note on HQL — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DIMARTINO ROSE | Director | Purchase | Jul 15, 2024 | 1,000 |
| GOETZ KATHLEEN | Director | Purchase | Apr 8, 2024 | 1,085 |
| MAHER C WILLIAM | Director | Purchase | Aug 22, 2024 | 0 |
| OMSTEAD DANIEL R | President | Purchase | Sep 24, 2023 | 197,518 |
| REIT TODD | Director | Purchase | Jan 1, 2024 | 1,000 |
| SABA CAPITAL MANAGEMENT L P | Beneficial Owner of more than 10% of a Class of Security | Purchase | Jun 25, 2024 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Saba Capital Management, L.P. | 12.54% | 3,429,991 | 46.20M | Sep 29, 2024 |
| Penserra Capital Management LLC | 2.84% | 776,002 | 10.45M | Sep 29, 2024 |
| Morgan Stanley | 1.79% | 489,687 | 6.60M | Sep 29, 2024 |
| Karpus Management, Inc. | 1.71% | 468,598 | 6.31M | Sep 29, 2024 |
| SIT Investment Associates Inc | 1.52% | 417,064 | 5.62M | Sep 29, 2024 |
| Needham Investment Management, L.L.C. | 1.29% | 352,719 | 4.75M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Amplify High Income ETF | 2.83% | 774,198 | 10.43M | Sep 29, 2024 |
| Exchange Listed Fds Tr-Saba Closed-End Funds ETF | 0.98% | 268,088 | 3.61M | Aug 30, 2024 |
| Saba Capital Income & Opportunities Fund II | 0.47% | 128,601 | 1.73M | Jul 30, 2024 |
| AQR Funds-AQR Diversified Arbitrage Fd | 0.31% | 84,499 | 1.14M | Sep 29, 2024 |
| Saba Capital Income & Opportunities Fd | 0.14% | 37,835 | 509.64K | Jul 30, 2024 |
| First Trust Income Opportunity ETF | 0.05% | 13,358 | 179.93K | Oct 30, 2024 |